Pharma


 Novartis launches new share buyback for up to 10% of its stock

Novartis launches new share buyback for up to 10% of its stock

March 13, 2023 05:19 PM AEDT | By Reuters

ZURICH (Reuters) - Novartis has launched a new share buyback programme to purchase up to 10% of the pharma company's own shares over the next three ye...


 Indonesia court hears class-action suit after children die from tainted cough syrup

Indonesia court hears class-action suit after children die from tain...

January 17, 2023 07:33 PM AEDT | By Reuters

JAKARTA (Reuters) - Families of Indonesian children who died because of tainted cough syrup demanded restitution as an Indonesian court on Tuesday sta...


 AstraZeneca signs COVID treatment deal with China's Genertec Meheco

AstraZeneca signs COVID treatment deal with China's Genertec Meheco

January 13, 2023 09:00 PM AEDT | By Reuters

BEIJING (Reuters) - AstraZeneca has signed a cooperation agreement with China's Genertec Meheco for COVID-19 antibody drug Evusheld, it said on Friday...


 U.S. to announce list of drugs for pricing negotiations Sept. 1

U.S. to announce list of drugs for pricing negotiations Sept. 1

January 12, 2023 03:11 AM AEDT | By Reuters

By Ahmed Aboulenein WASHINGTON (Reuters) - The U.S. government will announce a list of 10 prescription drugs for which it plans to negotiate the price...


 U.S. extends COVID-19 public health emergency status - CNBC

U.S. extends COVID-19 public health emergency status - CNBC

January 12, 2023 02:42 AM AEDT | By Reuters

(Reuters) -The United States on Wednesday extended the COVID-19 pandemic's status as a public health emergency until April, CNBC reported on Wednesday...


 China says talks to include Paxlovid in its health insurance drug list fail

China says talks to include Paxlovid in its health insurance drug li...

January 08, 2023 11:34 PM AEDT | By Reuters

BEIJING (Reuters) - China will not include Pfizer Inc's Paxlovid in an update to its list of medicines covered by basic medical insurance schemes as t...


 U.S. FDA grants priority review to Roche's bispecific antibody Glofitamab

U.S. FDA grants priority review to Roche's bispecific antibody Glofi...

January 06, 2023 05:34 PM AEDT | By Reuters

ZURICH (Reuters) - Roche announced on Friday the U.S. Food and Drug Administration has granted priority review to the Swiss pharmaceutical company's b...


 Rural residents worry for elderly as COVID rips across China

Rural residents worry for elderly as COVID rips across China

December 30, 2022 06:49 PM AEDT | By Reuters

By Martin Quin Pollard, Xiaoyu Yin and Tingshu Wang LEZHI (Reuters) - In a busy village clinic in Lezhi county in southwest China's Sichuan province o...


 Fosun's app allows users in China to register for BioNTech COVID vaccines In Hong Kong

Fosun's app allows users in China to register for BioNTech COVID vac...

December 27, 2022 07:57 PM AEDT | By Reuters

HONG KONG (Reuters) -China's Shanghai Fosun Pharmaceutical Group said users of its mobile health app in China can now register to take COVID-19 booste...


 India ready to export fever drugs to China amid COVID surge - export body

India ready to export fever drugs to China amid COVID surge - export...

December 23, 2022 04:35 AM AEDT | By Reuters

BENGALURU (Reuters) - India, one of the world's biggest drug makers, is ready to step up exports of fever medicines to China as it reels from a spike...


 China Meheco Group shares jump after agreement to import Pfizer's COVID treatment paxlovid

China Meheco Group shares jump after agreement to import Pfizer's CO...

December 15, 2022 12:46 PM AEDT | By Reuters

SHANGHAI (Reuters) - Shares of China Meheco Group surged after the Chinese drug seller signed an agreement with Pfizer Inc to import and distribute th...


 China Meheco to distribute Pfizer's COVID treatment in China

China Meheco to distribute Pfizer's COVID treatment in China

December 15, 2022 08:43 AM AEDT | By Reuters

HONG KONG (Reuters) - China Meheco Group Co Ltd said on Wednesday it signed an agreement with Pfizer Inc to import and distribute the U.S. drugmaker's...


 Japan's Meiji Holdings says drug unit started late-stage trial for COVID vaccine

Japan's Meiji Holdings says drug unit started late-stage trial for C...

December 13, 2022 05:47 PM AEDT | By Reuters

TOKYO (Reuters) - Japan's Meiji Holdings Co said on Tuesday its drug subsidiary had started a Phase III trial of an mRNA-based vaccine for COVID-19. M...


 Malaria deaths dip in 2021 after rising in first year of COVID, says WHO

Malaria deaths dip in 2021 after rising in first year of COVID, says...

December 08, 2022 10:17 PM AEDT | By Reuters

By Pratik Jain (Reuters) - Malaria-related deaths fell slightly in 2021 after a significant increase in the first year of COVID-19, but remained highe...


 AstraZeneca tops quarterly estimates buoyed by cancer drugs

AstraZeneca tops quarterly estimates buoyed by cancer drugs

November 10, 2022 09:46 PM AEDT | By Reuters

By Natalie Grover (Reuters) - AstraZeneca on Thursday raised its full-year adjusted earnings forecast after third-quarter profit and revenue topped an...


Recent Articles

 Tesla chief executive Elon Musk meets Chinese foreign minister in Beijing
May 30, 2023 12:24 PM AEST | By PAMEDIA

 Huawei revenue edges up in first quarter but profit margin narrows
April 28, 2023 10:56 AM AEST | By PAMEDIA

 Big investors dump China shares, add oil to portfolios -Goldman
April 17, 2023 11:44 PM AEST | By Reuters

 Tesla margins in focus as EV price war kicks into high gear
April 17, 2023 08:46 PM AEST | By Reuters

 Tesla Shanghai factory workers appeal to Elon Musk on bonus cuts
April 17, 2023 03:34 PM AEST | By Reuters


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK